L.J. Altfest & Co’s Regenxbio RGNX Stock Holding History

L.J. Altfest & Co’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,172	Closed	-$280K	–	291
2020 Q4	$280K	Buy	+6,172	New	+$216K	0.07%	209

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

L.J. Altfest & Co's RGNX Position: Q1 2021 in Review

L.J. Altfest & Co sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 6,172 shares — an estimated $280K sold.

L.J. Altfest & Co first reported a position in RGNX in Q4 2020 and held it in 1 quarter. The position peaked at $280K in Q4 2020. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

L.J. Altfest & Co reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
L.J. Altfest & Co sold 6,172 Regenxbio shares in Q1 2021, an estimated $280K.
L.J. Altfest & Co first reported a position in Regenxbio in Q4 2020 and held it in 1 quarter.
L.J. Altfest & Co's Regenxbio position peaked at $280K in Q4 2020.
184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on L.J. Altfest & Co's 13F filing for Q1 2021, filed 7 May 2021.